By Kris Gustafson, Vice President, Global Head of eCOA, IQVIA and J.C. Wilson, eCOA Product Manager, IQVIA
eCOAs are a clinical research innovation that improve the quality of data being collected from patients and address the need for a more patient-centric trial environment. These assessments capture outcomes from the patient’s perspective through a variety of validated measures, amplifying the patient’s voice while providing sponsors with vital information about the trial experience and patients’ quality of life. This unfiltered approach to collecting patient feedback also provides regulators and payers with new insights into treatment benefits, increasing the likelihood of approval and optimal reimbursement.
The value of these tools is undisputed, but the way they are developed by many vendors, using a waterfall methodology of software delivery, is highly inefficient wasting valuable time and increasing the likelihood of downstream design changes, defects, and ultimately causing delays in being ready for first-patient-in.
Instead, IQVIA is taking a more agile approach to eCOA development. Using our novel IQVIA eCOA platform and a collaborative, iterative design philosophy, our designers can produce a fully functional eCOA in a day.
This evolution in eCOA development is cutting months from the trial planning process, accelerating first patient in, and helping sponsors reduce time, cost, and risk in the trial environment – ultimately becoming another tool to help bring new therapies to patients faster.
The value of eCOA tools is undisputed, but using a waterfall methodology of software delivery is highly inefficient... IQVIA is taking a more agile approach to eCOA development and can produce a fully functional eCOA in a day.